Terms: = Breast cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Diagnosis
52 results:
1. Frontiers of Ovarian Carcinosarcoma.
Ismail A; Choi S; Boussios S
Curr Treat Options Oncol; 2023 Dec; 24(12):1667-1682. PubMed ID: 37938504
[TBL] [Abstract] [Full Text] [Related]
2. The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation.
Zheng J; Liu J; Yang W; Yao J; Guo J; Liu C
World J Surg Oncol; 2023 Jun; 21(1):181. PubMed ID: 37337182
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical Characterization of a Large Cohort of Triple Negative breast cancer.
Han R; Nofech-Mozes S; Boles D; Wu H; Curcin N; Slodkowska E
Int J Surg Pathol; 2024 Apr; 32(2):239-251. PubMed ID: 37306115
[No Abstract] [Full Text] [Related]
4. wt1 as a myoepithelial marker: a comparative study of breast, cutaneous, and salivary gland lesions.
Ng JKM; Li JJX; Lai BSW; Tsang JY; Chan AWS; Cheung CMT; Ip ECC; Tse GM
Hum Pathol; 2023 May; 135():76-83. PubMed ID: 36739952
[TBL] [Abstract] [Full Text] [Related]
5. Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.
Hol JA; Kuiper RP; van Dijk F; Waanders E; van Peer SE; Koudijs MJ; Bladergroen R; van Reijmersdal SV; Morgado LM; Bliek J; Lombardi MP; Hopman S; Drost J; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MCJ
J Clin Oncol; 2022 Jun; 40(17):1892-1902. PubMed ID: 35230882
[TBL] [Abstract] [Full Text] [Related]
6. [Clinicopathological features of verrucous hemangioma].
Fan PH; Liang D; Jia LJ; Gong YB; Sun B; Fu LL; Liu QY
Zhonghua Bing Li Xue Za Zhi; 2021 Dec; 50(12):1341-1345. PubMed ID: 34865421
[No Abstract] [Full Text] [Related]
7. Giant benign lymphangioendothelioma with positive expression of Wilms tumor 1: A case report.
Teixeira D; Canelhas Á; Costa M; Magalhães C; Ferreira EO; César A
J Cutan Pathol; 2022 Jan; 49(1):86-89. PubMed ID: 34423872
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological significance of wt1 expression in invasive breast carcinoma with >90% mucinous component.
Xu X; Bi R; Shui R; Yu B; Cheng Y; Tu X; Yang W
J Clin Pathol; 2022 Dec; 75(12):832-836. PubMed ID: 34244341
[TBL] [Abstract] [Full Text] [Related]
9. New mutation in wt1 gene in a boy with an incomplete form of Denys-Drash syndrome: A CARE-compliant case report.
Akramov NR; Shavaliev RF; Osipova IV
Medicine (Baltimore); 2021 May; 100(19):e25864. PubMed ID: 34106634
[TBL] [Abstract] [Full Text] [Related]
10. Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report.
Maeshima Y; Osako T; Morizono H; Yunokawa M; Miyagi Y; Kikuchi M; Ueno T; Ohno S; Akiyama F
J Med Case Rep; 2021 Feb; 15(1):78. PubMed ID: 33593410
[TBL] [Abstract] [Full Text] [Related]
11. GATA3 is a useful immunohistochemical marker for distinguishing sarcomatoid malignant mesothelioma from lung sarcomatoid carcinoma and organizing pleuritis.
Piao ZH; Zhou XC; Chen JY
Virchows Arch; 2021 Aug; 479(2):257-263. PubMed ID: 33570661
[TBL] [Abstract] [Full Text] [Related]
12. Correlation of miR-600 with wt1 expression and its potential clinical significance in breast cancer.
Pishbin F; Ziamajidi N; Abbasalipourkabir R; Najafi R; Farhadian M
Per Med; 2021 Jan; 18(1):31-42. PubMed ID: 33393369
[No Abstract] [Full Text] [Related]
13. Extra-abdominal ovarian cancer presenting with breast metastases at diagnosis: Case report and literature review.
Ferrari F; Ficarelli S; Forte S; Valenti G; Ardighieri L; Sartori E; Odicino F
Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():211-221. PubMed ID: 33152565
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of cell blocks from effusion specimens in Gynecologic Oncopathology: An experience of 220 cases, diagnosed at a Tertiary cancer Referral Center.
Rekhi B; Karmarkar S; Gupta C; Deodhar KK; Menon S; Pathuthara S; Maheshwari A; Shylasree TS; Gupta S
Indian J Pathol Microbiol; 2020; 63(3):427-434. PubMed ID: 32769333
[TBL] [Abstract] [Full Text] [Related]
15. Histological clues to the diagnosis of metastasis to the breast from extramammary malignancies.
Lee AHS; Hodi Z; Soomro I; Sovani V; Abbas A; Rakha E; Ellis IO
Histopathology; 2020 Aug; 77(2):303-313. PubMed ID: 32396659
[TBL] [Abstract] [Full Text] [Related]
16. Primary Peritoneal High-grade Serous Carcinoma Misinterpreted as Metastatic breast Carcinoma: A Rare Encounter in Peritoneal Fluid Cytology.
Park S; Cho EY; Oh YL; Park YH; Kim HS
Anticancer Res; 2020 May; 40(5):2933-2939. PubMed ID: 32366445
[TBL] [Abstract] [Full Text] [Related]
17. Ovarian metastases reported after adjuvant laparoscopic oophorectomies in breast cancer.
Cristian DA; Grama FA; Becheanu G; Popa I; Bratu AM; Burcoş T; Poalelungi CV; Şurlin V
Rom J Morphol Embryol; 2019; 60(3):913-920. PubMed ID: 31912104
[TBL] [Abstract] [Full Text] [Related]
18. Two rare cases of endosalpingiosis in the axillary sentinel lymph nodes: evaluation of immunohistochemical staining and one-step nucleic acid amplification (OSNA) assay in patients with breast cancer.
Shiino S; Yoshida M; Jimbo K; Asaga S; Takayama S; Maeshima A; Tsuda H; Kinoshita T; Hiraoka N
Virchows Arch; 2019 May; 474(5):633-638. PubMed ID: 30756183
[TBL] [Abstract] [Full Text] [Related]
19. breast metastasis two years after pelvic surgery and adjuvant chemotherapy for serous ovarian cancer.
Della Corte L; Giampaolino P; Fabozzi A; Cieri M; Zizolfi B; Morra I; Bifulco G
Gynecol Endocrinol; 2019 Mar; 35(3):211-213. PubMed ID: 30449229
[TBL] [Abstract] [Full Text] [Related]
20. Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Porcel JM
Ther Adv Respir Dis; 2018; 12():1753466618808660. PubMed ID: 30354850
[TBL] [Abstract] [Full Text] [Related]
[Next]